Clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae in pediatric inpatients in South China

Microbiol Spectr. 2023 Dec 12;11(6):e0283923. doi: 10.1128/spectrum.02839-23. Epub 2023 Oct 11.

Abstract

This study assessed the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae in pediatric inpatients at three hospitals in South China by means of screening stool samples for carbapenem-resistant genes and a nested case-control study to determine risk factors for carriage of carbapenem-resistant Enterobacteriaceae. Of 4,033 fecal samples screened, 158 (3.92%) were positive for CRE, including Escherichia coli (51.27 %), Klebsiella pneumoniae (37.97%), and Enterobacter cloacae (6.96%). The most common carbapenemase genes harbored by gastrointestinal CRE strains were blaNDM-5, blaNDM-1, and blaIMP-4. Hematological malignancies, respiratory diseases, otolaryngological diseases, nervous system diseases, oral administration of third-generation cephalosporins, and the combined use of two or more antibiotics were independently associated with CRE colonization.

Keywords: antimicrobial drug resistance; carbapenem-resistant enterobacteriaceae; children; enterobacteriaceae; multilocus sequence typing.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins / genetics
  • Carbapenem-Resistant Enterobacteriaceae* / genetics
  • Case-Control Studies
  • Child
  • Enterobacteriaceae Infections* / drug therapy
  • Enterobacteriaceae Infections* / epidemiology
  • Escherichia coli / genetics
  • Humans
  • Inpatients
  • Klebsiella pneumoniae / genetics
  • Microbial Sensitivity Tests
  • Molecular Epidemiology
  • beta-Lactamases / genetics

Substances

  • Bacterial Proteins
  • beta-Lactamases
  • Anti-Bacterial Agents